Overview

Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Dantrolene is used to prevent hyperthermia in intensive care patients suffering from subarachnoidal hemorrhage.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Dantrolene